Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Trauner, M; Halilbasic, E; Baghdasaryan, A; Moustafa, T; Krones, E; Fickert, P; Hofer, H; Penner, E.
Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment.
Dig Dis. 2012; 30 Suppl 1(6):39-47
Doi: 10.1159/000341123
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Trauner Michael
- Co-authors Med Uni Graz
- Baghdasaryan Anna
- Fickert Peter
- Halilbasic Emina
- Moustafa Tarek
- Tatscher Elisabeth
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Primary sclerosing cholangitis (PSC) is a chronic inflammatory bile duct disease of unknown etiology, frequently associated with inflammatory bowel disease and leading to end-stage liver disease requiring liver transplantation. Moreover, PSC is a premalignant condition associated with an increased risk for hepatobiliary and colorectal malignancy. Since effective medical therapy for PSC is still lacking, this disorder represents a potentially fatal disease with poor prognosis. This article is a summary of an overview given at the 5th Falk Gastro Conference in Munich 2012 and reviews the challenges associated with diagnosis, surveillance and therapy of PSC. Copyright © 2012 S. Karger AG, Basel.
- Find related publications in this database (using NLM MeSH Indexing)
- Cholangitis, Sclerosing - diagnosis Cholangitis, Sclerosing - drug therapy Cholangitis, Sclerosing - epidemiology Cholangitis, Sclerosing - therapy
- Humans -
- Population Surveillance -
- Ursodeoxycholic Acid - therapeutic use
- Find related publications in this database (Keywords)
- Cholestasis
- Cholangiocellular carcinoma
- Bile acids
- Nuclear receptors